Braingear gift creates Neuromodulation Center

BRAINGEAR ANNOUNCED a one million dollar sponsorship to support the Neuromodulation Center at Spaulding Rehabilitation Hospital. The Center is devoted to rigorous scientific exploration that could lead to new discoveries in brain performance. Braingear is a Swiss-based company founded by Jean Labuschagne, an innovator in the field of neuromodulation and non-invasive electroceuticals. Braingear is devoted to finding ways to leverage non-invasive electro-brain stimulation to improve brain performance in healthy individuals and creating strategic partnerships with progressive pharmaceutical companies to help impact the individuals suffering from mental and neurological disorders. Braingear’s research, development and applications in the field of randomized pulsed current stimulation (tPCS) were the first to remove the stigma and potential risks for low-intensity electro brain stimulation.

Felipe Fregni, PhD, one of the leading contemporary scientists on neuromodulation and transcranial direct current stimulation (tCDS), serves as the Center’s director. His research has focused on neuroplastic changes associated with conditions such as chronic pain, Alzheimer’s disease, depression and stroke using noninvasive brain stimulation as an investigative tool.

The Spaulding Neuromodulation Center laboratory is comprised of 15 research fellows and is a training center for clinical research and neuromodulation methodology. The product of discoveries from this partnership has the potential to help the global knowledge economy and impact interventions for mental and neurological disorders.

Spaulding is a remarkable pace with remarkable people and remarkable techniques. The program helped me in so many ways.

A Patient with Remarkable Recoveries

Connect with us